[1] Stringer KA, Mckay RT, Karmovsky A, Quémerais B, Lacy P. Metabolomics and its application to acute lung diseases. Front Immunol 2016;7:44. https://doi.org/10.3389/fimmu.2016.00044.
[2] Li P, Yin Y, Li D, Kim SW, Wu G. Amino acid and immune function. Br J Nutr 2007;98:237–52. https://doi.org/10.1017/S000711450769936X.
[3] Brunton L, Chabner BA, Knollman B. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw-Hill Education/Medical;2011.
[4] Inoue S, Ikeda H. Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2019;14:575–83. https://dx.doi.org/10.2147%2FCOPD.S188422.
[5] McCowen KC, Bistrian BR. Immunonutrition: problematic or problem solving? Am J Clin Nutr 2003;77:764–70. https://doi.org/10.1093/ajcn/77.4.764.
[6] Vetvicka V, Vetvickova J. Concept of immuno-nutrition. J Nutr Food Sci 2016;6:500. https://doi.org/10.4172/2155-9600.1000500
[7] Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations, Intern Med 2006;45;419–28. https://doi.org/10.2169/internalmedicine.45.1691.
[8] Morimoto K, Suzuki M, Ishifuji T, Taegashi M, Asoh N, Hamashige N, et al. The burden and etiology of community-onset pneumonia in the aging Japanese population: A multicenter prospective study. PloS One 2015;10, e0122247. https://doi.org/10.1371/journal.pone.0122247.
[9] Sapey E, Stockley RA. COPD exacerbations. 2: Aetiology. Thorax 2006;61:250–8. https://doi.org/10.1136/thx.2005.041822.
[10] Stockley RA, O’Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000;117;1638–45. https://doi.org/10.1378/chest.117.6.1638.
[11] Huerta A, Crisafulli E, Menéndez R, Martínez R, Soler N, Guerrero M, et al. Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics. Chest 2013;144:1134–42. https://doi.org/10.1378/chest.13-0488.
[12] Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163;1730–54. https://doi.org/10.1164/ajrccm.163.7.at1010.
[13] Beat M, Stephan H, Daiana S, Bingisser R, Mueller C, Leuppi J, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007;7:10. https://doi.org/10.1186/1471-2334-7-10.
[14] Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Imaizumi K, et al. Comparison of severity systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology 2008;13:731–5. https://doi.org/10.1111/j.1440-1843.2008.01329.x.
[15] Yamamoto H, Kondo K, Tanaka T, Muramatsu T, Yoshida H, Imaizumi A, et al. Reference intervals for plasma-free amino acid in a Japanese population. Ann Clinic Biochem 2016;53:357–64. https://doi.org/10.1177/0004563215583360.
[16] Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL, et al. Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun 2003;71:5803–13. https://doi.org/10.1128/iai.71.10.5803-5813.2003.
[17] Hoerr V, Zbytnuik L, Leger C, Tam PP, Kubes P, Vogal HJ. Gram-negative and gram-positive bacterial infections give rise to a different metabolic response in a mouse model. J Proteome Res 2012;11:3231–45. https://doi.org/10.1021/pr201274r.
[18] Su L, Li H, Xie A, Liu D, Rao W, Lan L, et al. Dynamic change in amino acid concentration profiles in patients with sepsis. PLoS One 2015;10:e0121933. https://doi.org/10.1371/journal.pone.0121933.
[19] Wannemacher RW Jr. Key role of various individual amino acids in host response to infection. Am J Clin Nutr 1977;30:1269–80. https://doi.org/10.1093/ajcn/30.8.1269.
[20] Morris SM Jr. Arginine: beyond protein. Am J Clin Nutr 2006;83:508S-512S. https://doi.org/10.1093/ajcn/83.2.508s.
[21] Cusumano ZT, Watson ME, Caparon MG Jr. Streptococcus pyogenes arginine and citrulline catabolism promotes infection and modulates immunity. Infect Immun 2014;82:233–42. https://doi.org/10.1128/iai.00916-13.
[22] Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005;5:641–54. https://doi.org/10.1038/nri1668.
[23] Banoei MM, Vogal HJ, Weljie AM, Kumar A, Yende S, Angus DC, et al. Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia. Crit Care 2017;21:97. https://doi.org/10.1186/s13054-017-1672-7.
[24] Cheng Z, Guo C, Chen Z, Yang T, Zhang J, Wang J, et al. Glycine, serine and threonine metabolism confounds efficacy of complement-mediated killing. Nat Commun 2019;10:3325. https://doi.org/10.1038/s41467-019-11129-5.
[25] Wheeler MD, Ikejema K, Enomoto N, Stacklewitz RF, Seabra V, Zhong SZ, et al. Glycine: a new anti-inflammatory immunonutrient. Cell Mol Life Sci 1999;56:843–56. https://doi.org/10.1007/s000180050030.
[26] Kurihara S, Shibakusa T, Tanaka KA. Cystine and theanine: amino acids as oral immunomodulative nutrients. SpringerPlus 2013;2:635. https://doi.org/10.1186/2193-1801-2-635.
[27] Nagao T, Nakayama H, Elahi M, Tada A, Toyonaga E, Yamasaki H, et al. L-histidine augments the oxidative damage against Gram-negative bacteria by hydrogen peroxide. Int J Mol Med 2018;7:2847–54. https://doi.org/10.3892/ijmm.2018.3473.
[28] Xu X, Zhang D, Zhang H, Wolters PJ, Killeen NP, Sullivan BM, et al. Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. J Exp Med 2006;203:2907–17. https://doi.org/10.1084/jem.20061232
[29] Basavanna S, Chimalapati S, Maqbool A, Rubbo B, Yuste J, Wilson RJ, et al. The effects of methionine acquisition and synthesis on Streptococcus pneumoniae growth and virulence. PLoS One 2013;8:e49638. https://doi.org/10.1371/journal.pone.0049638.
[30] Kim SJ, Chang J, Singh M. Peptidoglycan architecture of Gram-positive bacteria by solid-state NMR. Biochim Biophys Acta 2015;1848:350–62. https://doi.org/10.1016/j.bbamem.2014.05.031.
[31] Mullar A, Heseler K, Schmidt SK, Spekker K, Mackenzie CR, Walter D. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effect. J Cell Mol Med 2009;13:1125–35. https://doi.org/10.1111/j.1582-4934.2008.00542.x.
[32]Wannemacher RW Jr, Klainer AS, Dinterman RE, Beisel WR The significance and mechanism of an increased serum phenylalanine-tyrosin ratio during infection. Am J Clin Nutr. 1976 ; 29; 997-1006 Wannemacher RW Jr, Klainer AS, Dinterman RE, Beisel WR The significance and mechanism of an increased serum phenylalanine-tyrosin ratio during infection. Am J Clin Nutr. 1976 ; 29; 997-1006
[33] Ning P, Zheng Y, Luo Q, Liu X, Kang Y, Zhang Y, et al. Metabolic profiles in community-acquire pneumonia: developing assessment tools for disease severity. Crit Care 2018;22:130. https://doi.org/10.1186/s13054-018-2049-2.
[34] Laiakis EC, Morris GA, Fornace AJ, Howie SR. Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One 2010;5:e126555. https://doi.org/10.1371/journal.pone.0012655.
[35] Ethical guidelines for medical and health research involving human subjects. Ministry of Health, Labour and Welfare of Japan. 2015. http://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdf